XML 39 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock Plans (Tables)
3 Months Ended
Mar. 31, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Option Activity under Plans and Related Information

The following table summarizes option activity under the Plans and related information:

 

 

 

Options Outstanding

 

 

Weighted-

Average

Remaining

 

 

 

 

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic Value

(in thousands) (1)

 

Balances - January 1, 2016

 

 

1,949,089

 

 

$

39.27

 

 

 

8.09

 

 

$

47,480

 

Granted

 

 

48,260

 

 

$

53.59

 

 

 

 

 

 

 

 

 

Exercised or released

 

 

(19,474

)

 

$

30.29

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(41,422

)

 

$

43.68

 

 

 

 

 

 

 

 

 

Balances - March 31, 2016

 

 

1,936,453

 

 

$

39.62

 

 

 

7.86

 

 

$

25,732

 

Vested and expected to vest - March 31, 2016

 

 

1,729,309

 

 

$

38.72

 

 

 

7.78

 

 

$

24,226

 

Exercisable - March 31, 2016

 

 

784,409

 

 

$

32.48

 

 

 

6.94

 

 

$

14,863

 

 

(1)

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $50.50 of the Company’s common stock on March 31, 2016.

Summary of RSU Activity Outstanding and Weighted Average Grant Date Fair Value

The following table summarizes RSU activity under the Plans and related information:

 

 

 

Number of

Restricted

Stock Units

Outstanding

 

 

Weighted-

Average Grant

Date Fair Value

 

Unvested - January 1, 2016

 

 

1,898,025

 

 

$

49.53

 

Granted

 

 

704,760

 

 

$

51.32

 

Granted, performance RSUs

 

 

273,900

 

 

$

51.55

 

Released

 

 

(261,627

)

 

$

41.73

 

Cancelled or expired

 

 

(61,460

)

 

$

47.19

 

Unvested - March 31, 2016

 

 

2,553,598

 

 

$

51.09

 

 

Stock-Based Compensation Expense

The Company recognized stock-based compensation expense under the 2011 Stock Option and Incentive Plan, 2003 Stock Plan, Inducement Plans, 2011 Employee Stock Purchase Plan, and the Incapsula 2010 Share Incentive Plan in the condensed consolidated statements of operations as follows (in thousands):

 

 

 

For the three months ended March 31

 

 

 

2016

 

 

2015

 

Cost of revenue

 

$

1,393

 

 

$

914

 

Research and development

 

 

4,249

 

 

 

3,328

 

Sales and marketing

 

 

5,094

 

 

 

4,465

 

General and administrative

 

 

4,919

 

 

 

3,839

 

Total stock-based compensation expense

 

$

15,655

 

 

$

12,546

 

 

Weighted Average Assumptions for Fair Value of Stock Options Grants

The fair value of stock option grants for the three months ended March 31, 2016 and 2015 was estimated using the following weighted average assumptions:

 

 

 

For the three months ended March 31

 

 

 

2016

 

 

2015

 

Stock option grants:

 

 

 

 

 

 

 

 

Dividend rate

 

 

0

%

 

 

0

%

Risk-free interest rate

 

 

1.5

%

 

 

1.7

%

Expected term (in years)

 

 

6.1

 

 

 

6.1

 

Expected volatility

 

 

58

%

 

 

50

%